MML Investors Services LLC Makes New Investment in Smith & Nephew plc (NYSE:SNN)

MML Investors Services LLC bought a new stake in Smith & Nephew plc (NYSE:SNN) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 7,862 shares of the medical equipment provider’s stock, valued at approximately $245,000.

Other hedge funds have also made changes to their positions in the company. Allspring Global Investments Holdings LLC raised its stake in Smith & Nephew by 1,894.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 1,648 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Smith & Nephew by 92.5% in the second quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock valued at $61,000 after purchasing an additional 1,179 shares during the period. GAMMA Investing LLC raised its stake in shares of Smith & Nephew by 160.0% during the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock worth $70,000 after purchasing an additional 1,389 shares during the last quarter. Blue Trust Inc. lifted its holdings in shares of Smith & Nephew by 460.5% during the third quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider’s stock worth $145,000 after purchasing an additional 3,827 shares during the period. Finally, Coerente Capital Management purchased a new position in Smith & Nephew in the 3rd quarter valued at $202,000. Institutional investors and hedge funds own 25.64% of the company’s stock.

Smith & Nephew Price Performance

Smith & Nephew stock opened at $24.44 on Thursday. The company has a market cap of $10.68 billion, a P/E ratio of 12.47, a price-to-earnings-growth ratio of 1.41 and a beta of 0.84. Smith & Nephew plc has a one year low of $23.65 and a one year high of $31.72. The business has a fifty day moving average of $26.05 and a two-hundred day moving average of $27.87. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.

Analysts Set New Price Targets

Several analysts have recently commented on SNN shares. StockNews.com cut shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, November 12th. Deutsche Bank Aktiengesellschaft downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, November 1st. Finally, Berenberg Bank cut Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.